Beyond Shingles: What One Vaccine Study Tells Us About Ageing, HIV, and Research Equity
For people living with HIV, the landscape of health has shifted dramatically – and for the better. But with success comes new challenges. Thanks to antiretroviral therapy, HIV is no longer an automatic death sentence. In countries like Botswana, where treatment is widely available and most people achieve viral suppression, those living with HIV are growing older and living fuller lives. Yet, reaching old age opens a new chapter. Suddenly, things like heart disease, cancer, metabolic problems, and memory loss become more common – and they’re showing up earlier than in people without HIV. This means we can’t just focus on keeping the virus in check. We need to ask bigger, tougher questions: How do we prevent illness before it starts? What can we do about inflammation? How do we help people with HIV live not just longer, but healthier lives? One unexpected clue comes from an unlikely place: the shingles vaccine. A Surprising Signal from a Shingles Vaccine Study A large study lo...